Literature DB >> 26339360

Simulated microgravity affects ciprofloxacin susceptibility and expression of acrAB-tolC genes in E. coli ATCC25922.

Bingxin Xu1, Chenglin Li2, Yanhua Zheng3, Shaoyan Si3, Yuhua Shi4, Yuling Huang2, Jianzhong Zhang5, Yan Cui2, Yimin Cui4.   

Abstract

As a representative fluoroquinolone antibacterial, ciprofloxacin is frequently used to treat infections caused by bacteria such as E. coli. It is much meaningful to explore ciprofloxacin susceptibility and investigate a possible mechanism of drug susceptibility changes in E. coli ATCC25922 exposed to the environmental stress of simulated microgravity. The subculture of E. coli lasted for 7 days under simulated microgravity conditions (SMG) and normal microgravity (NG) conditions. On the 8th day, the cultures were divided into three groups: (1) NG group (continuous NG cultures); (2) SMG group (continuous SMG cultures); (3) SMCNG group (simulated microgravity change into normal gravity cultures). Ciprofloxacin (a final concentration of 0.125 μg/ml) sensitivity and expression of acrAB-tolC genes were detected in E. coli cells. The count and percentage of viable cells in the SMG cultures bacteria exposed to ciprofloxacin were higher than that in NG cultures and reduced to the levels of NG group when they were subcultivated from SMG to NG. The expressions of efflux pump genes (acrA, acrB and tolC) were upregulated in SMG culture and downregulated to the levels of NG group when they were subcultivated from SMG to NG. Susceptibility to ciprofloxacin and expression of acrAB-tolC genes in E. coli could be reversibly affected by SMG conditions. Over expression of efflux pump genes acrAB-tolC perhaps played an important role in decreased CIP susceptibility under SMG.

Entities:  

Keywords:  E. coli; Simulated microgravity; acrAB-tolC genes; ciprofloxacin; drug susceptibility

Mesh:

Substances:

Year:  2015        PMID: 26339360      PMCID: PMC4555688     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  Effects of simulated microgravity by RCCS on the biological features of Candida albicans.

Authors:  Wenjun Jiang; Bingxin Xu; Yong Yi; Yuling Huang; Xiao-Ou Li; Fuquan Jiang; Jinlian Zhou; Jianzhong Zhang; Yan Cui
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Inhibitory effects of a cured antibacterial bonding system on viability and metabolic activity of oral bacteria.

Authors:  Éfani C F Banzi; Ana R Costa; Regina M Puppin-Rontani; Jegdish Babu; Franklin García-Godoy
Journal:  Dent Mater       Date:  2014-05-28       Impact factor: 5.304

4.  Escherichia coli growth under modeled reduced gravity.

Authors:  Paul W Baker; Michelle L Meyer; Laura G Leff
Journal:  Microgravity Sci Technol       Date:  2004       Impact factor: 1.982

5.  Microgravity alters the physiological characteristics of Escherichia coli O157:H7 ATCC 35150, ATCC 43889, and ATCC 43895 under different nutrient conditions.

Authors:  H W Kim; A Matin; M S Rhee
Journal:  Appl Environ Microbiol       Date:  2014-01-31       Impact factor: 4.792

6.  Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages.

Authors:  Ning Li; Meiying Wang; Terry D Oberley; Joan M Sempf; Andre E Nel
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  Maintenance of antimicrobial susceptibility of Acinetobacter baumannii in modeled microgravity.

Authors:  Donna M Hensley
Journal:  Clin Lab Sci       Date:  2010

8.  Characterization of the morphology and genome of an Escherichia coli podovirus.

Authors:  Yuhui Hua; Xiaoping An; Guangqian Pei; Shasha Li; Wei Wang; Xiaomeng Xu; Huahao Fan; Yong Huang; Zhiyi Zhang; Zhiqiang Mi; Jiankui Chen; Jingyun Li; Feixiong Zhang; Yigang Tong
Journal:  Arch Virol       Date:  2014-08-28       Impact factor: 2.574

9.  Alveolar macrophage interaction with air pollution particulates.

Authors:  C A Goldsmith; C Frevert; A Imrich; C Sioutas; L Kobzik
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 10.  Spaceflight and modeled microgravity effects on microbial growth and virulence.

Authors:  Jason A Rosenzweig; Ohunene Abogunde; Kayama Thomas; Abidat Lawal; Y-Uyen Nguyen; Ayodotun Sodipe; Olufisayo Jejelowo
Journal:  Appl Microbiol Biotechnol       Date:  2009-10-22       Impact factor: 4.813

View more
  5 in total

1.  Response of human gut microbiota under simulated microgravity.

Authors:  Yijuan Han; Dongyan Shao; Cuicui Han; Qingsheng Huang; Wen Zhao
Journal:  Appl Microbiol Biotechnol       Date:  2022-07-07       Impact factor: 5.560

2.  Development of a Multicellular Three-dimensional Organotypic Model of the Human Intestinal Mucosa Grown Under Microgravity.

Authors:  Rosangela Salerno-Goncalves; Alessio Fasano; Marcelo B Sztein
Journal:  J Vis Exp       Date:  2016-07-25       Impact factor: 1.355

3.  The adaptation of Escherichia coli cells grown in simulated microgravity for an extended period is both phenotypic and genomic.

Authors:  Madhan R Tirumalai; Fathi Karouia; Quyen Tran; Victor G Stepanov; Rebekah J Bruce; C Mark Ott; Duane L Pierson; George E Fox
Journal:  NPJ Microgravity       Date:  2017-05-23       Impact factor: 4.415

4.  Response of extreme haloarchaeon Haloarcula argentinensis RR10 to simulated microgravity in clinorotation.

Authors:  Rebecca Thombre; Vinaya Shinde; Jyotsana Dixit; Sagar Jagtap; Pandit B Vidyasagar
Journal:  3 Biotech       Date:  2017-04-11       Impact factor: 2.406

5.  Exposure of Mycobacterium marinum to low-shear modeled microgravity: effect on growth, the transcriptome and survival under stress.

Authors:  Camille F Abshire; Kanchanjunga Prasai; Israel Soto; Runhua Shi; Monica Concha; Melody Baddoo; Erik K Flemington; Don G Ennis; Rona S Scott; Lynn Harrison
Journal:  NPJ Microgravity       Date:  2016-12-01       Impact factor: 4.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.